Catalyst Wire Dossier Catalyst Wire Dossier

CABENUVA

cabotegravir and rilpivirine · ViiV Healthcare Company
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for CABENUVA, covering 2021-01-21 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units". [NA]

See pricing